STOCK TITAN

If You Invested in Ambrx Biopharma Inc (AMAM)

NASDAQ
Looking for the current price? See the AMAM quote & overview
$1,000 invested 1 Year Ago
N/A
Trading since 2021-06-18
$1,000 invested 5 Years Ago
$2,222
+122.2% price return 40.4% CAGR
+122.2% with dividends reinvested
Bought on Oct 29, 2021 at $12.60 split-adjusted

What $1,000 or $10,000 in AMAM Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Jun 18, 2021
$1,000 — $2,222 +122% — $1,642 +64%
$10,000 — $22,222 +122% — $16,422 +64%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2024-03-06. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for AMAM

$1,000 Investment Over Time

AMAM vs S&P 500

Year-by-Year Returns

AMAM annual performance
Year Start Price End Price Annual Return Cumulative
2021 $17.05 $9.03 -47.0% -47.0%
2022 $9.03 $2.27 -74.9% -86.7%
2023 $2.27 $14.24 +527.3% -16.5%
2024 $14.24 $28.00 +96.6% +64.2%

About Ambrx Biopharma Inc

NASDAQ

Current Price
$28.00
View full AMAM overview

Frequently Asked Questions

Ambrx Biopharma Inc investment returns

How much would $1,000 invested in Ambrx Biopharma Inc be worth today?

If you invested $1,000 in Ambrx Biopharma Inc (AMAM) 5 years ago on 2021-10-29, your investment would be worth $2,222 as of 2024-03-06, a +122.2% price return without dividends, growing at a compounded rate of 40.4% per year (CAGR).

Has Ambrx Biopharma Inc outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare AMAM performance over available time periods.

What is Ambrx Biopharma Inc's average annual return?

The compound annual growth rate (CAGR) of AMAM’s share price over the past 5 years is 40.4%, without dividends. Individual years vary a great deal, and AMAM’s best recent full year was 2023 (+527.3%) while the worst was 2022 (-74.9%).

For informational and educational purposes only, not investment advice.